Evaxion Biotech (EVAX) Announces Clinical Collaboration with Merck (MRK) to Evaluate Lead Product Candidate with KEYTRUDA

Go back to Evaxion Biotech (EVAX) Announces Clinical Collaboration with Merck (MRK) to Evaluate Lead Product Candidate with KEYTRUDA
(NASDAQ: EVAX) Delayed: 3.07 +0.02 (0.66%)
Previous Close $3.05    52 Week High
Open $3.14    52 Week Low
Day High $3.18    P/E N/A 
Day Low $3.06    EPS
Volume 3,974       

Merck & Co. (NYSE: MRK) Delayed: 113.10 -0.77 (0.68%)
Previous Close $113.87    52 Week High $65.46 
Open $113.97    52 Week Low $47.97 
Day High $114.36    P/E 76.94 
Day Low $113.04    EPS $1.47 
Volume 1,104,796